Bacteria encounter a myriad of stresses in their natural environments, including, for pathogens, their hosts. These stresses elicit a variety of specific and highly regulated adaptive responses that not only protect bacteria from the offending stress, but also manifest changes in the cell that impact innate antimicrobial susceptibility. Thus exposure to nutrient starvation/limitation (nutrient stress), reactive oxygen and nitrogen species (oxidative/nitrosative stress), membrane damage (envelope stress), elevated temperature (heat stress) and ribosome disruption (ribosomal stress) all impact bacterial susceptibility to a variety of antimicrobials through their initiation of stress responses that positively impact recruitment of resistance determinants or promote physiological changes that compromise antimicrobial activity. As de facto determinants of antimicrobial, even multidrug, resistance, stress responses may be worthy of consideration as therapeutic targets.
Introduction
It is well known that in vivo susceptibility of bacteria to antimicrobials does not always match in vitro efficacy 1 and that mutational expression of antimicrobial resistance mechanisms can be selected or mutants expressing them enriched in the absence of antimicrobial exposure, 2, 3 indications that environmental conditions can impact bacterial susceptibility to antimicrobials. A significant environmental impact on bacteria is stress, which, in effecting a myriad of adaptive and protective responses, alters gene expression patterns and cell physiology in ways that can and do influence antimicrobial susceptibility. This occurs indirectly, as a result of stress-induced growth cessation or dormancy, 4 -6 since antimicrobials typically act on growing cells, 7 or directly as a result of the stress-dependent recruitment of resistance determinants (e.g. antimicrobial efflux), 8 changes to antimicrobial targets, 9 -11 amelioration of the adverse consequences of antimicrobial action, 12 -14 alterations to the membrane barrier functions, 9, 15, 16 generation of resistance mutations 17 or promotion of resistant growth modes (biofilms). 18 Moreover, since antimicrobials themselves are growth-inhibiting stressors that often elicit protective responses in bacteria, these agents can provoke their own resistance-promoting responses. 19 -21 This review highlights a variety of bacterial stress responses that have been linked to antimicrobial resistance (Table 1) , providing support for stress responses themselves being resistance determinants.
Nutritional stress
Antibiotics generally preferentially kill rapidly replicating bacteria 7 and it has been suggested that reduced growth and metabolic activity associated with non-optimal (e.g. nutrient-limited) growth environments might explain resistance in these instances. Certainly at least some of the resistance attributable to the biofilm mode of growth in Pseudomonas aeruginosa arises from established biofilm cells being largely oxygen starved and occurring in an anaerobic stationary phase/nongrowing state that renders them resistant to antimicrobials; by comparison, young biofilm cells are more aerobic, are growing and thus are antimicrobial susceptible. 22 Similarly, screening of active and dormant cells within a P. aeruginosa biofilm reveals that the latter are less susceptible to the aminoglycoside tobramycin. 23 A contributing factor to the antibiotic tolerance of anoxic P. aeruginosa biofilm cells appears to be their reduced metabolic activity-the addition of arginine (a fermentable nutrient) or nitrate/nitrite (to stimulate anaerobic respiration) enhanced antimicrobial killing of mature anaerobic (but not aerobic) biofilm cells. 24 Oxygen limitation also leads to a cessation of replication and the adoption of an antibiotic-tolerant state in Mycobacterium tuberculosis, 25 and it has been suggested that reduced growth and metabolic activity of quiescent M. tuberculosis infections is responsible for the observed in vivo antibiotic tolerance of this organism in the face of effective antibiotic activity in vitro. 26 The hypoxia-induced cessation of M. tuberculosis growth is an active process and is dependent upon hypoxia-promoted synthesis of triacylglycerol (TAG) by the hypoxia-inducible TAG synthase TgsI-under hypoxia, tsgI mutants are antibiotic susceptible. 27 TAG inhibition of M. tuberculosis growth results from a reduced TCA cycle flux and attendant decrease in metabolic activity. Interestingly, iron (Fe)-limiting growth conditions also induce TAG synthesis and antibiotic tolerance. Proteins that sense the indicated stress and/or play a role in recruiting the indicated resistance mechanism in response to the stress. cmeABC is peroxide inducible, although the impact of peroxide on antimicrobial resistance in C. jejuni has not been assessed. c Regulatory protein/system responsible has not been identified. d A link to environmental stress has yet to be demonstrated.
Nutrient limitation and the stringent response
A classic example of nutritional stress is amino acid deprivation, which activates what has long been known as the stringent response. 28 Associated with increased production of the alarmone guanosine 5 29 the stringent response is characterized by reduced expression of genes typically associated with growth and increased expression of survival genes that economize the use of scarce nutrients via a process known as transcriptional switching (i.e. starvation modulation of the housekeeping sigma factor s-70, such that its activity is diminished in favour of alternative sigma factors). 30 Activated by a variety of nutritional stresses [depletion of Fe, phosphate (Pi), carbon source or fatty acids], 30 the stringent response-mediated increase in ppGpp has a myriad of effects on bacterial cell physiology and, perhaps not surprisingly, impacts antimicrobial susceptibility. 10 For example, it has been known for some time that amino acid deprivation and the stringent response are linked to reduced penicillin susceptibility in Escherichia coli-relA mutants unable to synthesize ppGpp are more susceptible to penicillin-dependent lysis during amino acid deprivation 31 and the penicillin resistance of a mutant E. coli strain was similarly lost in the absence of relA.
32 Increases in ppGpp levels provided by the cloned relA gene in an otherwise wild-type E. coli are also associated with penicillin 33 as well as mecillinam 34 resistance, and the mecillinam resistance of in vitro-selected mecillinam-resistant mutants is associated with and dependent upon elevated ppGpp. 34 Fe limitation of E. coli has also been shown to increase ppGpp levels and mecillinam resistance. 35 Accumulation of ppGpp inhibits peptidoglycan 11 as well as phospholipid and fatty acid 36 synthesis, and this appears to be central to the ppGpp-promoted reduction in penicillin susceptibility in E. coli. Indeed, substrates of the phospholipid biosynthetic enzyme sn-glycerol-3-phosphate acyltransferase (PlsB) accumulate in response to elevated ppGpp, and overexpression of plsB overcomes this, relieving the fatty acid/phospholipid synthetic block 36 and restoring the penicillin susceptibility 33 of ppGpp-producing cells. Presumably plsB is a ppGpp target and ppGpp-dependent inhibition of phospholipid biosynthesis interferes with membrane-associated steps in peptidoglycan biosynthesis, thereby promoting penicillin resistance. ppGpp inhibition of cell wall synthesis has been described in other bacteria (Streptomyces coelicolor, Bacillus subtilis and M. tuberculosis) where it is also linked to reduced b-lactam susceptibility. 10 ppGpp is also linked to resistance to other antimicrobials-E. coli mutants deficient in ppGpp production are more susceptible to trimethoprim, gentamicin and polymyxin B. 37 Increased ppGpp accumulation in mutant E. coli is also linked to increased resistance to the peptide antibiotic microcin J25 38 and increased survivability in the presence of fluoroquinolones (FQs). 39 Antimicrobials (mupirocin, 40 vancomycin 40 and penicillin 33 ) themselves have been reported to stimulate ppGpp accumulation, but this has not been correlated with any increases in antimicrobial resistance save in Enterococcus faecalis, where a mutant unable to synthesize ppGpp showed increased susceptibility to vancomycin. 40 ppGpp production is also linked to vancomycin and bacitracin resistance in Streptomyces coelicolor. 41 Very recently ppGpp and the stringent response have been linked to resistance to several antimicrobials in nutrient-limited and biofilm cells of P. aeruginosa and the protective mechanism responsible elucidated. 14 Nguyen et al. 14 show that nutrientlimited planktonic and biofilm cells that are defective in the genes for ppGpp production (relA spoT) are markedly less resistant to antimicrobials than their wild-type counterparts, with ppGpp-deficient biofilm cells showing increased susceptibility to several classes of antimicrobials, including an aminoglycoside (gentamicin), a b-lactam (meropenem), a cationic antimicrobial peptide (CAP; colistin) and an FQ (ofloxacin). Interestingly, the mechanism of cell killing common to these agents relates to production of hydroxyl radicals ( . OH) 42, 43 and, indeed, ppGpp-deficient biofilm cells of P. aeruginosa showed elevated . OH formation and enhanced killing by oxidants such as paraquat, indicating that the increased antimicrobial susceptibility of relA spoT P. aeruginosa relates to increased oxidative stress.
14 The increase in . OH/oxidative stress in ppGpp-deficient cells was linked to increased production of 4-hydroxy-2-alkylquinolines (HAQs) previously implicated in intracellular signaling, 44 but also known to be pro-oxidant molecules 45 -deletion of HAQ synthetic genes obviated the increase in . OH formation in relA spoT mutants and restored resistance to antimicrobials.
14 Interestingly, increasing HAQ synthesis in otherwise wild-type cells had no impact on . OH levels or antimicrobial resistance, indicating that its pro-oxidant effects likely required a deficiency in antioxidant defences. In agreement with this, ppGpp-deficient cells showed reduced levels of catalase and superoxide dismutase activity that was independent of HAQ synthesis.
14 Apparently the stringent response promotes antimicrobial resistance by curtailing HAQ synthesis (thus avoiding its destructive pro-oxidant properties) and increases antioxidant defences, both of which serve to ameliorate the oxidative killing of cells upon exposure to antimicrobials. These results suggest that starved, non-growing cells may be at greater risk from oxidative stress/killing and so take steps to avoid it, and in so doing provide protection from the oxidative killing that is promoted by bactericidal antimicrobials. Of note, ppGpp-deficient E. coli also exhibited enhanced . OH formation and antimicrobial susceptibility relative to wild-type cells, 14 suggesting that the stringent response curtailing of oxidative stress in its promotion of antimicrobial tolerance may be a general feature of, at least, Gram-negative bacteria.
A recent detailed study of the effects of nutrient deprivation on antibiotic resistance in E. coli showed that phosphate starvation promoted a transient increase in resistance to the FQ ofloxacin, while amino acid starvation was linked to transient resistance to ofloxacin and ampicillin, and the combination of amino acid and glucose starvation led to prolonged resistance to ofloxacin and ampicillin. 46 While the mechanisms responsible were undefined, it appears that a number of stress responses were involved, with the SOS and stringent responses implicated for certain agents and/or starvation conditions. by the PhoPQ two-component system (TCS), where PhoQ, the sensor kinase, senses the nutrient limitation and activates the PhoP response regulator to up-regulate a variety of target genes that ultimately promote adaptation to this nutrient stress. 15 A subset of PhoP target genes has a role in the modification of lipopolysaccharide (LPS), divalent cations such as Mg 2+ playing a central stabilizing role in the barrier function of the outer membrane (OM) via an interaction with the LPS constituent of this membrane. 50 Significantly, a number of these PhoPQrelated modifications impact the activity of the CAP family of antimicrobials, which include the polymyxins [polymyxin B (PXB) and colistin] as well as the CAPs of innate immunity. 51 Thus loss-of-function phoPQ mutants show enhanced susceptibility to CAPs 47, 52 and Mg 2+ limitation promotes CAP resistance. 47 -49 Two of the more significant PhoPQ-stimulated loci from a resistance perspective are pagP and pmrAB.
51,53 pagB encodes a palmitoyltransferase that adds a palmitate chain to lipid A, thereby reducing OM fluidity and CAP entry while pmrAB encodes a TCS that controls a locus [pmrE (ugd)-pmrHFIJKLM; also known as arn] responsible for the synthesis and addition of 4-amini-arabinose (4AA) to lipid A, with the resulting increase in positive surface charge serving to reduce CAP binding to LPS and thus entry into cells. 51, 53 pmrAB is also activated by low environmental Fe 3+ and low pH, providing for 4AA modification of LPS and CAP resistance independently of PhoPQ and low Mg 2+ . 51 The PhoPQ-and PmrAB-controlled phosphoethanolamine (pEtN) transferases encoded by pmrC and cptA, respectively, also contribute modestly to CAP resistance under low Mg 2+ conditions, via their modification of LPS core heptose and lipid A, respectively, with positively charged pEtN. 51 Low Mg 2+ -responsive PhoPQ 47, 54, 55 and PmrAB 47,56 homologues have been described in other bacteria, including Yersinia pestis, 54 P. aeruginosa 55, 56 and Klebsiella pneumoniae, 47 where they similarly regulate LPS modification loci and contribute to CAP resistance. 47, 54, 56 In P. aeruginosa, too, there are several reports of phoQ 57, 58 and pmrB 57,59,60 mutations responsible for PXB 57, 59 and colistin 58, 60 resistance in clinical isolates dependent on Arnmediated LPS modification. 57, 58, 60 A phoP knockout in E. coli increases the susceptibility of the organism to ampicillin, 61 suggesting a link between this Mg 2+ -responsive TCS and b-lactam resistance, although a mechanism was not studied.
CAP (PXB) resistance has also been linked to Pi limitation in Pseudomonas fluorescens 62 and P. aeruginosa, 63 in parallel with an increase in the levels of a positively charged ornithine lipid (OL) in the membrane. While the overall increase in membrane positive charge might be expected to limit PXB binding, thus explaining resistance, and, indeed, reduced PXB binding to whole cells and isolated membranes was observed for Pi-limited P. fluorescens, 62 a study of a P. aeruginosa mutant unable to synthesize OL revealed the dispensability of this modification for PXB resistance under Pi-limiting conditions. 63 PXB binding to OMs of Pi-limited P. aeruginosa was nonetheless compromised, and this is likely explained by a reduced Pi content of the LPS, producing a less anionic surface macromolecule that binds cationic drugs less well.
Polyamines have also been linked to antimicrobial (quinolones, aminoglycosides and cationic peptides) resistance in P. aeruginosa, 64 and recently polyamine-mediated resistance to polycationic antimicrobials (aminoglycosides and CAPs) was shown to result from polyamine binding to OM/LPS, where it protected cells from the OM-disrupting effects of these agents. 65 Significantly, expression of polyamine synthetic genes in P. aeruginosa was induced in response to low Mg 2+ levels and exposure to CAPs, 65 confirming polyamine-mediated antimicrobial resistance as a stress response.
Oxidative stress
Organisms that grow aerobically are routinely exposed to oxidative stress in the form of reactive oxygen species (ROSs) [e.g. peroxide, superoxide (SO)] that are the unavoidable by-products of aerobic respiration. ROSs damage a variety of cellular macromolecules and thus elicit adaptive oxidative stress responses in bacteria intended to permit survival in the presence of this stressor. 66 Expression of a number of multidrug efflux systems is positively impacted by agents of oxidative stress, these efflux systems possibly playing a role in ameliorating the effects of this stress. Similarly, antioxidant mechanisms are recruited in response to antimicrobial exposure, antimicrobials being known to generate ROSs that are key to the often lethal effects of these agents. 42, 67 As such, oxidative stress responses have the potential to contribute to antimicrobial resistance in a variety of ways.
Redox-responsive regulators of multidrug efflux system
SoxRS, originally defined as an SO-responsive TCS that controls an adaptive SO stress response, since it was activated by redox-cycling agents (e.g. paraquat) that generated SO inside aerobically growing cells, 68 is now known to respond directly to these redox-cycling agents. 69 As univalent oxidants, these agents can, however, directly oxidize SoxR (to activate the SoxRS regulon), although their major toxic activities may well have to do with depletion of cellular NADPH, and thus interference with NADPH-requiring biosynthetic processes (i.e. SoxRS may be responding to a form of metabolic stress). 69 Nonetheless, an important component of the protective SoxRS-mediated response to redox-cycling agents is the AcrAB-TolC multidrug efflux system, with acrAB expression positively regulated by SoxS 70 in response to redox-cycling agents in E. coli 71 and Salmonella enterica serovar Typhimurium. 72, 73 Not surprisingly, then, mutations leading to constitutive soxS expression and elevated acrAB expression and antimicrobial resistance have been described in laboratory and/or clinical isolates of E. coli 74, 75 and Salmonella Typhimurium, 76 as well as S. enterica serovar Virchow, 77 S. enterica serovar Enteritidis 78 and K. pneumoniae 79 often as a result of mutations in soxR. 74, 76, 77, 79 SoxS also controls expression of the siRNA micF, whose expression reduces OmpF translation, with reduction of this OM porin serving to promote antimicrobial resistance by limiting antimicrobial uptake. 70, 80 Although few studies have examined the impact of SoxRSresponsive stresses on antimicrobial resistance, paraquat has been shown to enhance resistance of E. coli to enoxacin, dependent upon SoxRS, 81 although the contribution of AcrAB-TolC to this was not examined.
Intriguingly, redox-cycling agents have also been shown to induce SoxRS-dependent expression of the LPS core biosynthetic locus waaYZ in E. coli, where WaaY functions in the phosphorylation of core heptose residues. 82 waaYZ mutants are more susceptible to several antimicrobials, including norfloxacin, certain Review macrolides and b-lactams, likely because anionic Pi strengthens the OM permeability barrier by facilitating divalent cationmediated cross-bridging of LPS molecules, and its loss in the mutant compromises the OM barrier. 82 SoxRS thus appears to regulate LPS modification in response to redox-cycling agents, one that is intended to protect cells from these agents and the stresses they impart, and in so doing enhances resistance to other antimicrobials.
A number of additional regulators of multidrug efflux systems respond to oxidative stress, including MexR, the repressor of the mexAB-oprM multidrug efflux operon of P. aeruginosa; 83 MgrA, the global regulator in S. aureus that regulates .300 genes, including the major facilitator (MF) family antimicrobial efflux genes norA, norB and tet38; 84 and SarZ, an MgrA functional homologue that regulates several genes in S. aureus, including the norB and tet38 efflux genes. 85 In the case of MexR, in vitro oxidation of the protein with peroxide or cumene hydroperoxide caused the protein to dissociate from its target mexAB-oprM promoter DNA, thus in vivo exposure of P. aeruginosa to these ROSs produced a modest increase in mexAB-oprM expression. 83 Still, there was no indication that oxidative stress enhanced antimicrobial resistance in P. aeruginosa, 83 and transcriptomic studies of P. aeruginosa genes responsive to oxidative stress did not identify mexAB-oprM as being significantly (.2-fold) ROS inducible. 86, 87 The MgrA protein, like MexR, is sensitive to thiol-based oxidation (by peroxide or organic hydroperoxide), which also causes its dissociation from target DNA. 84 MgrA negatively regulates norA, encoding an FQ-exporting multidrug transporter, 88 norB, which encodes a multidrug transporter linked to norfloxacin and biocide resistance, 89 and tet38, which encodes a tetracycline exporter, 89 and an mgrA mutant shows elevated resistance to norfloxacin, biocides and tetracycline. 89 Thus oxidative stress might be expected to enhance efflux gene expression, and thus multidrug resistance in S. aureus, although this has yet to be tested. Low pH has also been shown to promote an MgrA-dependent increase in norB expression, leading to reduced susceptibility to norfloxacin. 90 Like MexR and MgrA, SarZ is sensitive to thiol-based oxidation, its binding to target DNA also being compromised upon oxidation. 85 While it negatively regulates known determinants of antimicrobial resistance such as norB and tet38, and a sarZ mutant shows reduced susceptibility to several antimicrobials, 85 the target genes whose derepression is responsible for this have not been confirmed and no evidence has been presented for oxidative stress promoting a SarZ-dependent increase in antimicrobial resistance.
ROS-mediated induction of multidrug efflux
Multidrug efflux systems of the Resistance-Nodulation-Division (RND) family, which are major determinants of intrinsic and acquired antimicrobial resistance in Gram-negative bacteria, are increasingly recognized as components of bacterial stress responses, including oxidative and nitrosative stress responses. 8 The mexXY genes of the P. aeruginosa MexXY-OprM multidrug efflux system that accommodates various antimicrobials (e.g. FQs, b-lactams, macrolides, tetracycline and aminoglycosides) are induced by oxidative stress, 3 mediated by the oxidative stress-inducible 86, 87 PA5471 gene product. 3 This efflux system is commonly associated with aminoglycoside resistance in clinical isolates, particularly cystic fibrosis (CF) lung isolates, where it is the primary determinant of aminoglycoside resistance. 91 The latter is an intriguing observation given that the CF lung is known to be rich in ROSs, 92 which may thus be promoting the development of PA5471-/MexXY-mediated aminoglycoside resistance in CF lung isolates. In agreement with this, in vitro exposure of P. aeruginosa to peroxide enhanced the frequency with which MexXY-dependent aminoglycoside-resistant mutants could be recovered, 3 in this way demonstrating a positive association between oxidative stress and antimicrobial resistance. Intriguingly, the mexXY operon is also induced by antimicrobials that target the ribosome (e.g. tetracycline, chloramphenicol, erythromycin, aminoglycosides), 19 as a result of their disruption of the ribosome, 93 and this is similarly mediated by the PA5471 gene product, which is also induced by these agents. 19 Consistent with translation disruption being the trigger for induction of PA5471 and mexXY, mutations that disrupt protein synthesis (fmt, folD) increase expression of PA5471 and mexXY. 94 In reconciling mexXY induction by both oxidative stress and ribosome disruption, one possibility is that oxidative stress also disrupts ribosome function or in some way perturbs translation. In this vein, ROSs have been shown to reduce translational fidelity in E. coli by interfering with the editing activity of an aminoacyl-tRNA synthetase. 95 Alternatively, since ribosome disruption via mutation or antibiotic exposure leads to the production of aberrant polypeptides that are prone to oxidative modification in E. coli, 96 it may be that oxidatively modified/damaged proteins are the common trigger for PA5471 and mexXY induction, with MexXY-OprM possibly playing some role in ridding the cells of these damaged/aberrant polypeptides. The RND family cmeABC multidrug efflux operon of Campylobacter jejuni was also shown to be peroxide inducible, although the influence of ROS on CmeABC-mediated antimicrobial resistance was not examined. 97 The mexAB-oprM locus, the major efflux determinant of intrinsic and acquired resistance to a variety of clinically relevant antimicrobials, particularly FQs and b-lactams, in lab and clinical isolates of P. aeruginosa, is also stress inducible-by chlorinated phenols such as pentachlorophenol (PCP). 98, 99 While PCP is a known uncoupler of oxidative phosphorylation, and thus will adversely impact energy production in the cell, the observation that PCP is a MexAB-OprM substrate 98 and is recognized by a regulator of mexAB-oprM expression, NalC, 99 suggests that it likely resembles a natural substrate for this efflux system. Still, PCP induction of mexAB-oprM can occur independently of NalC, apparently mediated by MexR, although this latter mexAB-oprM regulator does not bind PCP. 100 One possibility is that PCP promotes oxidative stress that impacts the redox-sensitive MexR 83 directly. PCP has, for example, been shown to dramatically increase O 2 flux in P. aeruginosa, generating an oxidative stress that could impact MexR activity. multidrug-resistant nfxC 106 and mexS 107 mutants. 103 Moreover, several of the MexT targets identified in an array study of the MexT regulon 108 were also shown to be induced in response to nitrosative stress, 103 suggesting that MexT controls a regulon with some function in a nitrosative stress response. Interestingly, chloramphenicol but not the related florfenicol, which lacks a nitro group, induces mexEF-oprN expression, again dependent upon MexT. 103 This highlights the importance of the nitro moiety of chloramphenicol for this induction, an interesting observation given that some common products of nitrosative stress in bacteria are nitrated amino acids (i.e. chloramphenicol may resemble a nitrated nitrosative stress product that is an intended signal for MexT and substrate for MexEF-OprN). The observation that XenB, implicated in removal of nitro groups from nitroglycerine and trinitrotoluene in Pseudomonas, 109, 110 is co-regulated with mexEF-oprN by nitrosative stress is consistent with these playing a role in 'detoxifying' nitrated products of nitrosative stress.
Antibiotic-dependent oxidative stress-protective mechanisms
Given the observation that ROSs (i.e. . OH) and the oxidative stress that results from antimicrobial exposure are generally associated with the lethal effects of bactericidal antimicrobials, 42, 43, 67 it stands to reason that antioxidant/oxidative stress-protective responses in bacteria would promote antimicrobial resistance. Certainly elimination of ROS defence genes in E. coli has been correlated with increased antimicrobial susceptibility. 111 A possible oxidative stress protective mechanism that promotes antimicrobial resistance in E. coli involves indole, an extracellular signalling molecule whose production is promoted by exposure to antimicrobials 12 and, possibly, oxidative stress-ROSs induce the tnaA tryptophanase gene whose product catalyses the synthesis of indole. 112 Interestingly, addition of the . OH-scavenging compound DMSO reduces antimicrobial-dependent indole production, 113 consistent with indole being inducible by the ROSs formed as a result of antimicrobial exposure and providing an explanation for antimicrobial induction of indole production. Most importantly, endogenous indole production as well as exogenous indole addition promotes antimicrobial resistance. 12 Indole production by highly antibiotic-resistant strains of E. coli has also been shown to promote resistance in otherwise susceptible members of a heterogeneous population. 114 Its promotion of resistance in the latter study was apparently due to its up-regulation of resistance mechanisms that included, interestingly, oxidative stress-protective mechanisms. 114 Indole has also been shown to enhance the antimicrobial resistance of P. aeruginosa.
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Despite the known toxicity of NO for bacteria, endogenous NO production by bacteria is known, catalysed by bacterial nitric oxide synthases (bNOSs), where it protects bacteria (B. subtilis) from the damaging effects of ROSs. 116 bNOSs have also been shown to protect Bacillus sp. against a variety of antimicrobialsmutants lacking bNOS activity show enhanced antimicrobial susceptibility 117 -in part by alleviating the lethal effects of oxidative stress that result from antimicrobial exposure. 42, 43, 67 While bNOS gene inducibility by oxidative stress in Bacillus has not been examined and antibiotic exposure fails to induce bNOS gene expression, preliminary evidence suggests that the b-lactam antimicrobial cefuroxime stimulates bNOS activity in B. subtilis.
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Thus environmental stress conditions can impact NO production, and thus antimicrobial resistance in this organism. Bacterial production of another gas, H 2 S, has also been linked recently to antimicrobial resistance-deletion of genes for H 2 S synthesis in Bacillus anthracis, S. aureus, P. aeruginosa and E. coli rendered cells susceptible to multiple antimicrobials. 118 Again, the protective effect of H 2 S was due, in part, to its mitigation of antibioticdependent oxidative stress-promoted lethal damage to these organisms. 118 Regulation of H 2 S production and/or activity/expression of H 2 S synthetic proteins/genes was not assessed, so it is not yet clear whether this antimicrobial resistance mechanism will be impacted by environmental growth (i.e. stress) conditions. Antioxidant strategies are, nonetheless, clearly important for antimicrobial resistance in bacteria, and thus environmental conditions that activate protective antioxidant genes/enzymes will promote antimicrobial resistance.
Polyamines also contribute to resistance to ROSs in E. coli, both in functioning as antioxidants 119 and in promoting expression of antioxidant/oxidative stress-protective genes. 119 -121 Recently a modest positive impact of antibiotics on polyamine production was seen in E. coli, and this appeared to alleviate, to some extent, antimicrobial-dependent ROS production and render cells less susceptible to antimicrobials. 13 A recent report of in vitro-selected FQ-resistant Proteus mirabilis lacking prototypical target site mutations in gyrA, gyrB or parC but showing an antioxidant phenotype (reduced lipid and protein oxidation compared with a wild-type strain) 122 highlights a possible link between oxidative stress and FQ resistance in this organism. One possibility is that an antioxidant phenotype provides for protection against the FQ-dependent oxidative damage that is key to the lethal activity of these agents.
Envelope stress
Environmental affronts to cell envelope structure and function are met with adaptive responses in bacteria intended to permit survival in the face of that affront. These so-called envelope stress responses are highly regulated, typically by alternate sigma factors referred to as extracytoplasmic function (ECF) sigmas and TCSs (Table 2) , and there are often multiple response pathways in a given microorganism. In E. coli, for example, there are envelope stress response systems controlled by the sigma factor RpoE (s E ) 123 and the TCSs CpxRA 124 and BaeSR, 125 each responsive to its own set of specific envelope 'stressors' (Table 2) . Similarly, B. subtilis boasts four sigma factors (SigB, SigM, SigW and SigX) and at least two TCSs (BseRS and LiaRS) that respond to envelope stress, with unique and common stress 'triggers' amongst the six ( Table 2 ). Given that many antimicrobials either target components of the cell envelope or must overcome the barrier provided by the cell envelope to gain access to targets within the cell, it is perhaps not surprising that changes manifested by envelope stress responses in the face of envelope stress can impact antimicrobial susceptibility.
TCSs: Gram-negative bacteria
A variety of TCSs respond to envelope stress in Gram-negative bacteria, each reacting to different stressors and thus different physiological triggers that in many cases remain unknown. The Review 
CpxRA
CpxRA generally responds to stresses that adversely impact cell envelope protein folding, and thus plays a role in envelope maintenance. 126 Triggering the E. coli CpxRA-dependent response promotes reduced susceptibility to b-lactams, 127 aminoglycosides, 127 ,128 novobiocin 127 and CAPs, 129 in part as a result of CpxRA-dependent up-regulation of multidrug efflux 127, 130 and peptidoglycan amidase 129 genes. Mutations have also been identified in cpxA that are responsible for modest resistance to aminoglycosides 131 and b-lactams, 132 and cloned cpxR promotes modest resistance to aminoglycosides (kanamycin) 130 and b-lactams. 133 Interestingly, CpxRA also regulates expression of the major porin genes ompF and ompC in a manner reminiscent of EnvZ-OmpR-mediated osmoregulatory control of these genes 134 (see below)-activation of the CpxRA pathway increases expression of ompC at the expense of ompF. 135 OmpF is a major portal for entry of antimicrobials such as b-lactams (OmpC forms a smaller channel) and reduced ompF expression has been linked to b-lactam resistance. 136 Whether this explains CpxRA-promoted b-lactam resistance is, however, unclear. Paradoxically, CpxRA is activated by aminoglycosides and plays a role in aminoglycoside killing, being required for the generation of toxic . OH that is formed upon membrane disruption by aminoglycoside-generated aberrant polypeptides and is responsible for killing of aminoglycoside-treated cells. 43 As such, cpxRA mutants show transiently reduced susceptibility to aminoglycosides. 43 Interestingly, however, ROS generation in aminoglycoside-exposed cells has also been linked to antimicrobial resistance development as a result of ROS-promoted mutation. 137 
AmgRS
The amgRS locus in P. aeruginosa encodes a homologue of the E. coli OmpR-EnvZ TCS and was first identified in a screen of transposon-insertion mutants susceptible to aminoglycosides. 138 Unlike OmpR-EnvZ, however, AmgRS regulates a number of membrane transporter and protease genes more reminiscent of the E. coli CpxRA envelope stress response and does so in response to aminoglycoside exposure. 138 It has been suggested that AmgRS responds to envelope stress mediated by aberrant polypeptides that are proposed to accumulate upon aminoglycoside treatment, 43 with the AmgRS-controlled stress response functioning to protect cells from aberrant peptide-mediated membrane damage. 138, 139 In support of this, a number of AmgRS-regulated protease and other genes have been shown to contribute to aminoglycoside resistance, their loss in mutants comprising resistance. 140 The observation that an amgRS mutant is more sensitive to alkaline and salt stress, and more susceptible to b-lactams, suggests that, like E. coli CpxRA, it may be a general envelope stress response regulator in P. aeruginosa.
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BaeSR
The BaeSR envelope stress-triggered TCS in E. coli 125 is induced by possible membrane stressors sodium tungstate and plant flavanoids 141 and promotes resistance to these 141 as well as bile salts and novobiocin, 142, 143 dependent upon the MdtABCD multidrug efflux system whose expression is positively regulated by BaeSR.
1,125,141 -143
PhoPQ
Membrane-disrupting CAPs, including PXB and proteins of innate immunity, also trigger stress responses whose outcomes are a strengthening of membranes and, in the case of Gram-negative organisms, modification of the LPS to prevent CAP binding, 9 LPS being the initial site of CAP interaction with cells. 144 In S. enterica 15 and K. pneumoniae 145 this is mediated by the PhoPQ TCS that also responds to growth-limiting Mg 2+ and involves the same set of LPS modification genes (see above). In P. aeruginosa, CAP-promoted LPS modification is mediated by the ParRS TCS and not by PhoPQ. 146, 147 In all cases, however, subinhibitory CAP exposure ultimately promotes LPS modification and resistance to CAPs, with these TCSs thus mediating inducible CAP resistance. 145, 146 ParRS also mediates CAP induction of the mexXY multidrug efflux operon that is linked to aminoglycoside resistance in P. aeruginosa. Resistance to these antimicrobials has been linked to the indicated stress response regulators. c Originally described in B. subtilis as a two-component system, LiaRS, which responded to alkaline shock, organic solvents, detergents, CAPs and cell wall-active agents (vancomycin, bacitracin and nisin). 
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Rcs phosphorelay system
Phosphorelay systems, more complex versions of TCSs that include additional components beyond the sensor kinase and response regulator, 148 have also been linked to envelope stress and antimicrobial resistance. The RcsCDB/F phosphorelay system that is widely distributed in the Enterobacteriaceae and was originally implicated in the regulation of capsular synthesis in E. coli is one such system, being activated by envelope stress (high osmolarity, desiccation, low temperature, high Zn 2+ ), 149 PXB 150 and peptidoglycan-disrupting b-lactams (e.g. cefsulodin and methicillin). 150 Interestingly, rcsB deletion mutants are b-lactam susceptible, suggesting that this system may control a global protective response to cell wall stress. 150 Consistent with this, mutational activation of the Rcs relay enhances b-lactam resistance independent of capsule synthesis. 150 The Rcs relay has also been linked to PXB resistance in Salmonella Typhimurium. 151 
TCSs: Gram-positive bacteria
A number of TCSs responding to cell envelope stressors have been reported in Gram-positive bacteria, many of which have been linked to antimicrobial resistance. In most instances, however, this link comes from observations of enhanced antimicrobial susceptibility of mutants defective in these systems and not through any demonstration that they mediate envelope stress-dependent enhancement of resistance. Exceptions to this include the BceRS TCS found in S. aureus 152 and Streptococcus mutans 153 and the BraRS TCS also of S. aureus, 154 which respond to the envelope-stressing antimicrobials bacitracin 152, 153 and bacitracin and nisin, 154 respectively. In both cases, however, the stress-responsive TCSs activate genes that promote resistance to these agents specifically, with BraRS activating genes encoding an efflux transporter responsible for detoxifying bacitracin and nisin. 154 Thus these TCSs may not be envelope stress responsive per se.
LiaRS
LiaRS is a cell envelope stress responsive TCS first described in B. subtilis, where it is activated by exposure to alkaline shock, organic solvents, detergents and lipid II (peptidoglycan intermediate) cycle inhibitors (vancomycin, bacitracin, nisin) and CAPs. 155, 156 This system, which functions as a three-component LiaFRS system in S. mutans and is similarly cell envelope stress inducible in this organism, has been linked to bacitracin, vancomycin and chlorhexidine resistance-LiaFRS 2 mutants are susceptible to these agents. 157 Moreover, a mutation in LiaF has been shown to contribute to daptomycin resistance in E. faecalis. 158 The LiaRS homologue in S. aureus, VraSR, is also induced by cell wall-active antibiotics (b-lactams, glycopeptides, bacitracin, cycloserine) 159, 160 and CAPs, 161 and controls many cell wall genes. 159 Its inactivation increases b-lactam, 159,160,162 glycopeptide (vancomycin and teicoplanin), 160 ,162 bacitracin 160 and fosfomycin 160 susceptibility in methicillin-resistant S. aureus (MRSA) strains and CAPs, bacitracin, teicoplanin and b-lactam susceptibility in a type strain of this organism. 161 Up-regulation of the VraSR-dependent cell wall stress stimulon is also linked to intermediate vancomycin resistance in clinical isolates of S. aureus [vancomycin intermediate S. aureus (VISA)]. 163 Mutations in vraRS are commonly seen in S. aureus showing intermediate resistance to teicoplanin 164, 165 and are responsible for intermediate vancomycin resistance in some VISA isolates, 166 -168 presumably as a result of activation of the VraRS stimulon. Finally, a transcriptomic study of Listeria monocytogenes highlighted the roles of several TCSs, including LiaRS, in this organism's cell envelope stress response to the b-lactam cefuroxime, with many TCS-regulated genes implicated in cell envelope functions or resistance to cefuroxime and other cell envelope stressors. 169 
NsaRS
NsaRS is a TCS in the firmicute group of Gram-positive bacteria (e.g. Bacillus, Staphylococcus, Streptococcus, Listeria, Enterococcus) that modulates cell envelope stability by sensing disruptions in this structure. 170 In S. aureus, for example, it is activated by cell envelope-damaging antimicrobials such as fosfomycin, ampicillin, nisin, gramicidin, carbonyl cyanide m-chlorophenylhydrazone (CCCP) and penicillin, and regulates a variety of genes, including those associated with cell wall synthesis. 170 While an nsaS mutant showed a 200-fold reduced ability to develop resistance to bacitracin, suggesting this TCS might contribute to antimicrobial resistance, the drug susceptibility of this mutant was unaltered relative to wild-type. 170 However, nsaS mutations were found in nisin-resistant S. aureus, suggesting that NsaRSregulated genes are linked to resistance to this agent. 171 
GraRS
GraRS (also known as Aps) is yet another envelope stressresponsive TCS in S. aureus, one that responds to CAPs, including PXB, 172 -174 and that has been linked to vancomycin 166, 173 and CAP 173, 174 resistance in this organism. Thus graR knockout mutants are hypersusceptible to vancomycin and PXB, and more susceptible to some anti-staphylococcal CAPs. 166, 173, 174 Similarly, overexpression of graRS is seen in clinical VISA strains, with inactivation of this locus increasing susceptibility to vancomycin and PXB. 16 GraRS-promoted resistance appears to result from an increased net positive surface charge as a result of its induction of genes associated with production of lysylphosphatidyl glycine (L-PG) (mprF) 16, 173 and addition of D-Ala to teichoic acids (dltABCD), 16 the increased L-PG content of membranes and masking of anionic teichoic acids with D-Ala serving to reduce the binding of cationic agents such as vancomycin and PXB. 16, 174 Increased L-PG incorporation as a result of a gain-of-function mutation in mprF has also been linked in part to daptomycin resistance in S. aureus.
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CroRS
The croRS genes encode a second envelope stress-responsive TCS in E. faecalis, one that is inducible by b-lactams and other peptidoglycan inhibitors (fosfomycin, cycloserine, moenomycin, ramoplanin, vancomycin and bacitracin). 176 A croRS mutant exhibited a 4000-fold increase in susceptibility to ceftriaxone, a b-lactam for which resistance in E. faecalis is linked to production of penicillin-binding protein (PBP) 5. 176 Interestingly, the pbp5 gene was expressed in the mutant, and a plasmid bearing the pbp5 gene failed to restore the mutant's ceftriaxone Review 2077 JAC resistance, 176 indicating that some as yet unknown CroRScontrolled gene mediates PBP5-dependent ceftriaxone resistance in this organism.
Sigma factors: Gram-negative bacteria
The major cell envelope stress response sigma factor in E. coli and other Gram-negative bacteria, s E , has been linked in a limited way to antimicrobial resistance. In E. coli, s E has been shown to negatively control the PhoPQ TCS that promotes resistance to CAPs as a result of LPS modification, providing a link between envelope stress and LPS modification/CAP resistance in this organism. 177 s E also plays a role in resistance to CAPs in Salmonella Typhimurium, 178 to vancomycin and bacitracin in S. coelicolor 41 and to nalidixic acid, penicillin and vancomycin in Corynebacterium glutamicum. 179 Perhaps the clearest link between envelope stress, s E and antimicrobial resistance involves the mexCD-oprJ multidrug efflux operon of P. aeruginosa. Originally shown to be induced by a variety of membrane-active biocides (chlorhexidine and benzalkonium chloride) and dyes (ethidium bromide and rhodamine), 180 mexCD-oprJ was more recently shown to be inducible by a variety of membrane-damaging agents (MDAs), including detergents, organic solvents, biocides and CAPs. 181 Consistent with envelope stress being a signal for MexCD-OprJ recruitment, this induction was mediated by the algU-encoded envelope stress response sigma factor, 181 a functionally equivalent homologue of E. coli RpoE 182 that was first described as a regulator of alginate biosynthesis in P. aeruginosa. 183, 184 While MexCD-OprJ would appear to be a component of an envelope stress response in this organism, its role in this is unclear. The exometabolome of an nfxB mutant hyperexpressing MexCD-OprJ does, however, show elevated levels of long-chain fatty acids, which have been proposed as possible MexCD-OprJ substrates. 185 Perhaps this efflux system plays a role in fatty acid export as part of a system for exchanging these components of membrane lipids as the cell responds to envelope stress and restructures its membranes accordingly. How AlgU responds to MDAs in promoting mexCD-oprJ expression is as yet unknown.
Sigma factors: Gram-positive bacteria
No fewer than four envelope stress response sigma factors have been described in the Gram-positive bacterium B. subtilis (SigB, SigM, SigW and SigX), with homologues often present in other Gram-positive organisms. These have been linked in a limited way to resistance to b-lactams and other cell-wall active agents. B. subtilis SigM is activated by cell envelope stress elicited by antibiotics and by heat, acid, ethanol and superoxide stress, 186 and sigM mutants are more susceptible to bacitracin, 187 ,188 ampicillin 188 and moenomycin. 188 B. subtilis SigW responds to a variety of cell envelope stresses, including that promoted by cell wall-active antimicrobials, 189 and this sigma factor has been linked to fosfomycin, vancomycin and ampicillin resistance -sigW deletion mutants show increased susceptibility to these agents.
188 B. subtilis sigX is induced by inhibitors of peptidoglycan biosynthesis and tunicamycin 190 and its deletion in lab-constructed mutants renders B. subtilis more susceptible to CAPs, 63, 188, 191 ampicillin 188 and bacitracin. 188 The SigB general stress response sigma factor, 192 which responds to various stresses, including heat, salt, acid, nitrosative, cell wall, nutritional and energy stress, 193, 194 has been described in B. subtilis, Bacillus cereus, L. monocytogenes and S. aureus. 195 In B. subtilis this sigma factor is linked to rifampicin resistance-a sigB mutant is more susceptible to this antimicrobial. 196 In S. aureus, SigB expression or activation is linked to CAP, 197 glycopeptide 198, 199 and b-lactam resistance, 200 including methicillin, 198 with methicillin and glycopeptide resistance dependent upon the SigB-regulated spoVG TCS genes. 198 Inactivation of sigB also increases the oxacillin susceptibility of MRSA 201 and reverses the increased oxacillin and vancomycin resistance of in vitro-selected pine oil cleaner-resistant S. aureus mutants, 202 highlighting its contribution to acquired resistance in this organism. Finally, SigB is linked to disinfectant, 203 tetracycline, 204 gentamicin 204 and b-lactam 205 resistance in L. monocytogenes, with sigB mutants showing increased susceptibly to these agents.
Heat stress
Aminoglycoside induction of heat shock genes has been reported in E. coli, 206 Acinetobacter baumannii 207 and P. aeruginosa. 208 In the case of P. aeruginosa, this is mediated by the alternate Lon protease AsrA, whose expression is induced in response to tobramycin or heat shock, dependent upon the RpoH heat shock sigma factor. 208 Intriguingly, asrA overexpression in an engineered strain had a modest positive impact on aminoglycoside resistance, 208 raising the possibility that the heat shock response might protect to some extent against aminoglycoside challenge. In agreement with this, pre-treatment of A. baumannii cells for 30 min at 458C rendered the organism better able to withstand a subsequent streptomycin challenge as compared with cells pre-treated at 378C. 207 One explanation for the link between aminoglycosides and heat shock is that components of the heat shock response charged with eliminating misfolded proteins might target the aberrant mistranslated polypeptides that are produced by aminoglycoside-disrupted ribosomes and that insert into and disrupt bacterial membranes. 139 Aminoglycosidemediated membrane damage has been reported 139 and is likely a key step in the lethal activity of these agents, 43, 138 and thus elimination of aberrant polypeptides that may be responsible would certainly reduce their toxicity to cells. Heat shock has also been linked to b-lactam resistance, in the form of the ClpL heat shock chaperone that is found mainly in Gram-positive bacteria. In Streptococcus pneumoniae its expression is associated with increased penicillin resistance-an overproducing mutant shows a 4-fold increase in resistance while a ClpL 2 mutant shows a 4-fold decrease, both relative to wild-type. 209 Interestingly, clpL is induced upon exposure of S. pneumoniae to penicillin (or a heat shock), where it positively influences both expression of the pbp2x cell wall synthesis gene and stability of its PBP2x product 209 and in so doing enhances penicillin resistance. Similarly, treatment of S. aureus with cell wall-active antimicrobials that inhibit peptidoglycan biosynthesis was shown to induce a number of heat shock genes (dnaK, groES, clpB and clpL), 210, 211 although there was no indication that this impacted antimicrobial susceptibility. Heat has also been linked to antimicrobial resistance in Cronobacter sakazaki, an emerging foodborne pathogen, 212 and induction of a heat shock response Review leads to macrolide resistance in Lactococcus lactis, 213 although no mechanisms were proposed.
General stress response
The rpoS gene, which encodes the general stress response sigma factor that responds to nutrient starvation, hyperosmolarity, pH downshift, non-optimal high and low temperature in E. coli 214 and heat shock, hyperosmolarity and prolonged peroxide exposure in P. aeruginosa 215 has been linked to antibiotic resistance in both E. coli and P. aeruginosa. In E. coli, for example, constitutive expression of rpoS partially suppressed the drug hypersusceptibility of a mutant E. coli lacking the acrAB multidrug efflux genes. 216 Similarly its overexpression was shown to partially restore ofloxacin tolerance in an ofloxacin-susceptible LasIR 2 P. aeruginosa defective in acylhomoserine lactone production and quorum-sensing-dependent gene expression. 217 Conversely, an rpoS mutant strain of P. aeruginosa showed enhanced susceptibility to carbapenems, though only in the stationary phase. 218 Interestingly, RpoS was also shown to be required for a heat shock-promoted increase in carbapenem resistance in P. aeruginosa, 218 a clear example of a stress response sigma factor mediating stress-promoted antimicrobial resistance. Still, the RpoS targets responsible for resistance in P. aeruginosa or E. coli are unknown. Recently RpoS has been linked to persister formation in E. coli and P. aeruginosa-rpoS null mutants showed increased formation of E. coli persisters resistant to ampicillin and ciprofloxacin and P. aeruginosa persisters resistant to ciprofloxacin, 219 providing yet another way in which this sigma factor can contribute to antimicrobial resistance.
ClpXP is a protease that is broadly distributed in bacteria, where it is charged with turning over damaged proteins as part of the cell's protein quality control systems. 220 The clpP gene encoding the proteolytic component of ClpXP is induced by heat shock and other stresses in Gram-negative 221 and Grampositive 222, 223 bacteria and is important for stress toleranceclpP mutants are susceptible to heat and other stresses. 222 -225 Recently clpP mutations in S. aureus have also been shown to confer reduced susceptibility to vancomycin in several VISA isolates, 226 while clpP null mutants of P. aeruginosa showed modest (2-fold) increases in susceptibility to ciprofloxacin, 227 highlighting a link, hitherto unexplained, to antimicrobial resistance.
Stress-induced mutagenesis
In the face of 'growth-limiting' stress owing to nutrient starvation, hypoxia, low pH, increased osmotic pressure, extreme temperature shifts or antimicrobial exposure, bacteria activate a stress-induced increase in the mutation rate (reviewed in Galhardo et al., 17 Cirz and Romesberg 20 and Foster 228 ). Also called adaptive mutagenesis, stress-induced mutagenesis arises from a stress-dependent introduction of double-stranded breaks in chromosomal DNA 229 and subsequent activation of error-prone repair under the control of the SOS response that typically follows DNA damage, 230 the RpoS-mediated general stress response 231 and the sigma E (s E )-dependent envelope stress response. 232 Presumably the increased mutation rate enhances the likelihood that mutations permitting adaptation to the stressor will arise. Since the stress-induced mutations are random, however, and unrelated to the initial stress that triggered mutagenesis, non-selected mutations, including those that impact antimicrobial resistance, also arise. 20 While studied predominantly in E. coli, 17, 20, 228 evidence for stressinduced mutagenesis is also seen in B. subtilis, 233 Pseudomonas putida, 234 Caulobacter crescentus 235 and bile 249 have also been shown to induce the SOS response and error-prone repair in certain bacteria and thus increase the mutation rate. 244, 248, 249 FQ (e.g. ciprofloxacin) promotion of ciprofloxacin resistance development as a result of the induction of the SOS response and error-prone mutagenic pathway is well documented 20 and there are reports of these agents promoting SOS response pathway-dependent development of b-lactam resistance as well. 246 Non-antibiotic stresses impacting mutational events have also been seen, including UV light exposure promoting SOS response-dependent development of ciprofloxacin resistance in S. aureus 237 and osmotic stress promoting chromosomal DNA rearrangements in E. coli. 251 This is significant because mutations in ampD are common in AmpC-overproducing b-lactam-resistant bacteria. 252 
SOS response
The SOS response is activated by a number of 'stresses' (DNA damage, exposure to certain antimicrobials, pH extremes, oxidative stress, nutrient starvation 253 ) and thus has the potential to promote antimicrobial resistance under a variety of stress conditions. Moreover, its contribution to resistance extends beyond its roles in stress-induced mutagenesis and chromosomal rearrangements. b-lactam stimulation of the SOS response in E. coli, for example, facilitates survival of a lethal b-lactam exposure as a result of an SOS response-promoted transient halt in cell division. 6 Because b-lactams only act on growing cells, the halt in cell division is protective. Expression of qnrB, one of several plasmid-borne quinolone-resistance (qnr) genes widespread in the Enterobacteriaceae, is ciprofloxacin inducible, dependent on the drug's induction of the SOS response. 254, 255 Activation of the SOS response has recently been shown to be important for ciprofloxacin and rifampicin resistance development in E. coli, with suppression of this response blocking emergence of resistance to these agents in vitro 256 and enhancing FQ killing of drug-resistant, biofilm and persister cells of E. coli.
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The SOS response also contributes to resistance development by promoting the horizontal dissemination of drug resistance genes-activation of the SOS response in V. cholerae by ciprofloxacin as well as other stresses induces transfer of an antimicrobial resistance gene-carrying integrative conjugative Review 2079 JAC element (ICE) called STX. 258 The expression, and thus the activity of integron-encoded recombinases dubbed integrases, is also enhanced under circumstances that activate the SOS response. 259 Integrons are mobile genetic elements that typically carry multiple antibiotic resistance genes or cassettes, with integrases catalysing recombination events that result in the capture of new resistance genes/cassettes or the reshuffling of integronresident resistance genes to promote their expression. 260 As such, the SOS response can promote acquisition and expression of resistance genes by integron elements, thereby promoting resistance development. Antibiotics known to stimulate the SOS response are capable of activating integrase expression and activity, 259 an interesting observation given that many of today's common integrons carry genes for resistance to these agents. 253 Binding sites for the LexA regulator of the SOS response are prevalent in the integrase gene promoters of a wide variety of integrons (and superintegrons, large chromosomally located integrons carrying many genes, including antibiotic resistance genes 260 ) found in a wide range of bacterial species, 261 suggesting that SOS control of integrase-mediated integron capture and expression of antibiotic resistance genes is common in the bacterial world.
Persisters
The ability of a small subpopulation of an apparently susceptible and genetically homogeneous population of bacteria to survive antibiotic exposure has been known for some time.
5,262 These so-called persisters are slow-growing or dormant organisms, slow growth and dormancy effectively protecting them from the lethal impact of antibiotics, which preferentially act on rapidly growing bacteria. 5 Persisters are an example of the phenotypic heterogeneity that exists naturally within genetically homogeneous microbial populations 262 and are suggested to arise either stochastically (randomly) and continuously during population growth (so-called type II or stochastic) or are formed in response to an external (i.e. environmental) trigger (type I or determinative). 5, 262 Their presence ultimately increases the fitness of a bacterial population by ensuring that a proportion of its members are able to survive insults (e.g. antimicrobial exposure) that would otherwise eradicate a phenotypically homogeneous population. For example, the antimicrobial resistance of biofilms has been attributed to persisters, 23, 263 as has the recalcitrance of chronic infections (e.g. P. aeruginosa CF lung infections, M. tuberculosis lung infections) to antimicrobial therapy. 264, 265 A possible link between persisters and stress was first made by Korch et al., 266 who showed that persistence in E. coli was correlated with production of the ppGpp alarmone. These researchers showed that increasing ppGpp production with the cloned relA gene increased the frequency of persister formation and that compromising ppGpp production in a high-persistence mutant (one that yielded persisters at a high frequency) reduced or eliminated this high-persistence phenotype. 266 Still, there was no evidence that stress or stress-mediated ppGpp production enhanced persister formation. Indeed, there is some controversy over whether persister formation can, in fact, be inducible, although there is a report of ciprofloxacin treatment promoting the formation of ciprofloxacin-resistant persisters in E. coli, dependent, interestingly enough, on the SOS response. 21 Recent data suggest that toxin -antitoxin (TA) gene pairs/modules play an important role in persister formation. 267 Apparently the toxin components of these modules target key constituents of macromolecular synthesis and, in shutting them down, compromise growth (but not viability). 5 Thus stochastic or stress-mediated increases in toxin levels would promote dormancy, and thus formation of antibioticresistant persisters. Consistent with this model, expression of the relE gene encoding a known inhibitor of translation was shown to promote persister development in E. coli. 268 Moreover, TA genes are known to be expressed in drug-resistant persisters 21 and the aforementioned SOS response-mediated ciprofloxacininducible persister formation seen in E. coli is dependent on the SOS response-inducible TA locus tisAB/istR-knockout of this locus dramatically reduced the levels of ciprofloxacin-resistant persisters. 269 Of note, too, ciprofloxacin induces expression of the tisB toxin gene, and TisB-expressing cells are multidrug tolerant. 269 Additional support for stress being a trigger for persister formation comes from the demonstration that E. coli experiencing increased endogenous stress as a result of mutational inactivation of stress response genes or increased exogenous stress as a result of exposure to peroxide or acid pH produced markedly elevated levels of ampicillin-resistant persisters compared with wild-type or untreated cells. 219 
Small-colony variants (SCVs)
SCVs are a slow-growing auxotrophic subpopulation of bacteria that have been described in a number of bacteria, 4,270 including S. aureus, where they have been linked to antimicrobial resistance.
4,270 S. aureus SCV auxotrophies typically impact the electron transport chain and/or the TCA cycle, ultimately compromising ATP production, and thus growth, and generation of an electrochemical gradient across the cytoplasmic membrane. 4, 270 The slow growth of S. aureus SCVs reduces susceptibility to b-lactam antibiotics that typically act on growing cells while the reduced electrochemical gradient reduces susceptibility to aminoglycosides, which depend on it for uptake into cells. Selectable in vitro 271, 272 and in vivo 271, 273 with aminoglycosides, it is unclear whether S. aureus SCVs arise from natural (e.g. antibiotic) selection of auxotrophic mutants or in response to the growth inhibitory stress imposed by antibiotics. In a recent article, however, aminoglycosides were shown to markedly enhance SCV recovery in vitro and in an animal model of S. aureus mastitis, dependent on the SigB stress response sigma factor. 271 In addition, in vitro aminoglycoside-selected as well as clinical SCVs showed evidence of SigB activation, 271 again consistent with SigB (and thus environmental stress) playing a role in SCV formation. The S. aureus growth inhibitory molecule 4-hydroxy-2-heptylquinoline-N-oxide (HQNO), a P. aeruginosa exoproduct, also promotes SigB-dependent SCV formation by S. aureus, 274 further highlighting SCV formation and the attendant antimicrobial resistance as a stress response. Still, details of the mechanisms responsible for SCV formation remain largely unknown.
Stress-induced biofilm formation
In nature and in the infected host 275 bacteria commonly exist in biofilms that, among other benefits, provide resistance to antimicrobials. 276 Environmental factors that promote bacterial biofilm Review formation will thus contribute positively to antimicrobial resistance. A variety of stresses have been linked to biofilm formation, with biofilm formation itself possibly being a stress response. 18 The observation, for example, that inactivating mutations in the rpoS gene encoding the general stress response sigma factor hampers biofilm formation by E. coli 18,277 supports biofilm formation being a stress response. Nutrient limitation (i.e. nutrient stress) in the form of Fe limitation has also been shown to promote biofilm formation in S. aureus 278 and Legionella pneumophila, 279 while Mg 2+ limitation has a positive impact on biofilm formation in P. aeruginosa. 280 The latter arises from a low Mg 2+ -dependent repression of the retS 'biofilm repressor' gene, which is ultimately mediated by PhoPQ. 280 Fe limitation also increases transcription and translation of known biofilm determinants as well as biofilm quantity in the periodontopathogen Aggregatibacter actinomycetemcomitans. 281 Still, limiting Fe can also negatively impact biofilm formation in some organisms (e.g. P. aeruginosa 282 ) , and high metal levels have been shown to have a positive impact on biofilm formation by a number of organisms. 283 Ribosome disruption by ribosome-targeting agents (ribosome stress) also leads to strong biofilm induction in E. coli as a result of a SpoT-dependent decrease in ppGpp and an increase in the biofilm-promoting second messenger c-di-GMP [bis-(3 ′ -5 ′ )-cyclic di-GMP]. 284 In this way the ppGpp alarmone links ribosome status to genes necessary for initiation of biofilm formation. ppGpp is also linked to biofilm formation in E. faecalis, as mutants unable to synthesize this alarmone exhibit a diminished ability to sustain biofilm formation. 285 Oxidative stress has also been implicated in biofilm formation by E. coli. An antitoxin, MqsA, that represses RpoS, leading to a reduction in c-di-GMP levels and thus a reduction in biofilm formation, is degraded (by the Lon protease) in response to oxidative stress. 286 Although not specifically studied, the resultant oxidative stress-promoted increase in rpoS expression 286 would be expected to enhance biofilm formation. RpoS has also been implicated in low-temperature-promoted biofilm development in E. coli.
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Concluding remarks
Despite the link between stress and known antimicrobial resistance determinants, in many instances the contribution of the resistance genes to the stress response itself is unknown or unconfirmed. While several of the RND family multidrug exporters of P. aeruginosa are stress inducible, their roles in the corresponding stress responses and the identities of the inducing signals/effector molecules remain uncertain. Beyond fostering an understanding of the biology of these exporters, knowledge of the environmental circumstances and/or effector molecules responsible for recruiting multidrug efflux systems has relevance in terms of the potential generation of these effectors in vivo (in hospital or at a site of infection), where their induction of these resistance determinants may compromise antimicrobial chemotherapy. Knowing where and when a particular resistance mechanism might be recruited in vivo could inform an appropriate choice of therapeutic options. Interestingly, stressor induction of these efflux systems does not appear to enhance resistance, 3, 109, 187 their documented contributions to resistance being limited to circumstances of mutational overexpression. 288 This is true, as well, of other stress response-linked resistance genes, where mutational activation of stress response pathways has been linked to antimicrobial resistance (e.g. mutations in soxRS and several of the cell envelope stress response TCSs; see above) while, for the most part, stress activation of these pathways has not. Nonetheless, given that resistance determinants such as efflux are components of stress responses, the relevant stresses will provide a selective pressure for effluxexpressing antimicrobial-resistant mutants even in the absence of antimicrobials. Indeed, in vitro exposure of P. aeruginosa selects for MexXY-expressing pan-aminoglycoside-resistant mutants, 3 and growth in a mouse model of pneumonia selects for mutants expressing various RND pumps. 2 Still, given their link to antimicrobial resistance, mutations in stress response pathways may well be selected by the antimicrobials themselves, independent of the cognate stress.
The fact that antimicrobials themselves are growthcompromising agents that activate bacterial stress responses also has important implications for antimicrobial resistance development, given the link between stress and resistance. While there are clear examples of stress-regulated genes/processes implicated in clinically relevant antimicrobial resistance (e.g. RND efflux systems and LPS modification in P. aeruginosa, 288 cell envelope stress-responsive TCS targets in VISA isolates, 16,163,166 -168 possibly biofilms 276 and persisters 264, 265 in several bacteria and SCVs in S. aureus 271, 273 ), in many cases the link between stress response genes/mutations and resistance in clinical strains is lacking and/or the impact on resistance is modest and unlikely to afford clinical resistance. Still, antimicrobial resistance in clinical strains is often multifactorial, 288 and even modest stress-related antimicrobial resistance, 'recruited' by stress induction or mutation, may well contribute to resistance development in vivo. Stress response pathways may thus be suitable targets for therapeutic intervention. In support of this, inactivation of the AmgRS regulators of an envelope stress response in P. aeruginosa increases susceptibility to aminoglycosides, 144 loss of the AlgU envelope stress response sigma factor reverses the resistance of a mutant P. aeruginosa hyperexpressing MexCD-OprJ, 187 and inactivation of the SOS response compromises FQ-promoted persister formation by E. coli 21 and renders cells more susceptible to FQs. 287 In addition, inactivation of the stringent response in P. aeruginosa and E. coli enhances susceptibility to several antimicrobials as well as survivability of P. aeruginosa in infected and antimicrobial-treated animals.
14 Ultimately, too, since antimicrobial lethality is typically dependent upon hydroxyl radical production/oxidative stress, which can be countered by bacterial antioxidant responses, targeting such responses may be generally useful in promoting antimicrobial efficacy. Still, a better understanding of the link between stress and antimicrobial resistance, including the identification of the stress-induced effectors that promote resistance and/or recruit resistance determinants and the genes involved, is needed in order to fully appreciate the importance of stress responses as resistance determinants, their value as therapeutic targets and how best to target them. 
